TEL AVIV, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal ...
Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based ...
Hosted on MSN
Nasus Pharma highlights transformational 2025 as NS002 intranasal epinephrine program advances and IPO completes
An announcement from Nasus Pharma Ltd. ( (NSRX)) is now available. On December 22, 2025, Nasus Pharma Ltd. released a shareholder letter from CEO Dan Teleman highlighting a transformational year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback